This can't help



















5 years ago they could have bought them for 2 billion, basically. But both S-P and Merck were too arrogant to believe that Vertex had a better drug than they did. Now the market cap is too large and their would be constraint of trade to deal with in the HCV biz.
 




Just wondering, could Merck possibly buy Vertex? Or vice versa? At least I can dream.

It won't work even if we want to because of anti-trust and we'll never divest boceprevir for the sake of buying out Vertex because then all senior EC clowns would have to swallow a humble pie and say they do, then they will equally lose all credibility. Victrelis is just another Aggrastat - let the first year of press die out and then they will not be talking about it anymore.
 
















Not going to happen. Vertex has a marketing agreement with J+J. If done right, J+J would probably get to keep the rights upon any 'buy-out.'

When we thought the Titanic, I mean Merck, had sunk and settled on the bottom, we now find it was on an underwater cliff and has fallen further into the crevice. Merck is toxic and ignorant in so many ways, The stock is probably overpriced, sad for just how low it currently is.